RI
FSTX

RTW Investments’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

RTW Investments’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-62,274
Closed -$4.2M – 34
2017
Q3 		$4.2M Sell
62,274
-226
-0.4% -$12.9K 0.73% 22
2017
Q2 		$3.38M Buy
+62,500
New +$2.89M 0.71% 22

Other funds holding FSTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TA
Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
MAM
Morse Asset Management Darien, Connecticut $481M AUM 46% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

RTW Investments's FSTX Position: Q4 2017 in Review

RTW Investments sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q4 2017, closing a stake of 62,274 shares — an estimated $4.2M sold.

RTW Investments first reported a position in FSTX in Q2 2017 and held it in 2 quarters. The position peaked at $4.2M in Q3 2017. 38 funds tracked by Wall St. Rank hold FSTX as of Q4 2017.

  • RTW Investments reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • RTW Investments sold 62,274 F-star Therapeutics, Inc. Common Stock shares in Q4 2017, an estimated $4.2M.
  • RTW Investments first reported a position in F-star Therapeutics, Inc. Common Stock in Q2 2017 and held it in 2 quarters.
  • RTW Investments's F-star Therapeutics, Inc. Common Stock position peaked at $4.2M in Q3 2017.
  • 38 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q4 2017.

Based on RTW Investments's 13F filing for Q4 2017, filed 14 Feb 2018.